VRDN | NASDAQ

Viridian Therapeutics, Inc.De

Viridian Therapeutics, Inc.De (VRDN) | runway 34.0 months | financing risk lower | market cap $1.4B. Daily snapshot of financials, capital pressure, and rece...

Company websiteLast updated Apr 29, 2026

Share price

$13.30

As of Apr 29, 2026

Market cap

$1.4B

Snapshot valuation

30D volume

3.0M shares

Rolling average daily volume

Runway

34.0 months

Estimated from precomputed burn and cash

Financing risk

N/A

Current liquidity and recent financing activity do not point to an immediate capital raise.

Snapshot summary

Runway: 34.0 months based on estimated burn.

Financing signal: Current liquidity and recent financing activity do not point to an immediate capital raise.

Latest development: Viridian Therapeutics, Inc.\DE 8-K 2026-03-30.

Recent developments

Viridian Therapeutics, Inc.\DE 8-K 2026-03-30

8-K filed on 2026-03-30.

Mar 29, 2026, 8:00 PM

Viridian Therapeutics, Inc.\DE 10-K 2026-02-26

10-K filed on 2026-02-26.

Feb 25, 2026, 7:00 PM

Viridian Therapeutics, Inc.\DE 8-K 2026-02-26

8-K filed on 2026-02-26.

Feb 25, 2026, 7:00 PM

Viridian Therapeutics, Inc.\DE 10-Q 2025-11-05

10-Q filed on 2025-11-05.

Nov 4, 2025, 7:00 PM

Viridian Therapeutics, Inc.\DE 8-K 2025-11-05

8-K filed on 2025-11-05.

Nov 4, 2025, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures